Complete Bibliography

Visit PubMed to view Dr. Philip Greenberg's complete publication record.

Selected Publications

Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains. Harris DT, Hager MV, Smith SN, Cai Q, Stone JD, Kruger P, Lever M, Dushek O, Schmitt TM, Greenberg PD, Kranz DM. Journal of immunology (Baltimore, Md. : 1950). 2018; 200(3):1088-1100.

Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro. Schmitt TM, Aggen DH, Ishida-Tsubota K, Ochsenreither S, Kranz DM, Greenberg PD. Nature biotechnology. 2017; 35(12):1188-1195

A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia. Oda SK, Daman AW, Garcia NM, Wagener F, Schmitt TM, Tan X, Chapuis AG, Greenberg PD. Blood. 2017; 130(22):2410-2419.

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma. Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR. Cancer immunology research. 2017; 5(11):978-991.

miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation. Ban YH, Oh SC, Seo SH, Kim SM, Choi IP, Greenberg PD, Chang J, Kim TD, Ha SJ. Cell reports. 2017; 20(11):2598-2611.

MicroRNA-150 modulates intracellular Ca 2+ levels in naïve CD8+ T cells by targeting TMEM20. Kim TD, Jung HR, Seo SH, Oh SC, Ban Y, Tan X, Min Kim J, Hyun Lee S, Koh DS, Jung H, Park YJ, Ran Yoon S, Doh J, Ha SJ, Choi I, Greenberg PD. Scientific reports. 2017; 7(1):2623.

Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. Anderson KG, Stromnes IM, Greenberg PD. Cancer cell. 2017; 31(3):311-325.

Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In Vivo. Chapuis AG, Desmarais C, Emerson R, Schmitt TM, Shibuya K, Lai I, Wagener F, Chou J, Roberts IM, Coffey DG, Warren E, Robbins H, Greenberg PD, Yee C. Science immunology. 2017; 2(8).